Innovation for Health - 14 February 2019
Global Investor Forum Contact
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare

Ton Rijnders

Scientific Director, Lygature & The European Lead Factory

Ton Rijnders holds a PhD in molecular biology. He joined Organon in 1986. In 2003 Ton moved to the position of Vice President Research at Organon. In this position he had responsibility for a wide portfolio of discovery and preclinical development projects and for an extensive portfolio of collaborations in Europe and the USA. After the acquisition of Organon by Schering-Plough in 2007, Ton was appointed VP Discovery and Site Head Oss within the Schering-Plough Research Institute. He represented Schering-Plough at the Research Directors Group of EFPIA that has responsibility for the interactions with the European Commission. He continued to head Discovery in Oss within the Merck Research Labs after the merger of Merck with Schering-Plough until September 2011. He was one of the founding fathers of TI Pharma, a public private partnership in drug discovery which manages a portfolio of over 50 consortia with a total investment of around 300 m€. As of November 2011 Ton has taken up responsibility as Scientific Director at TI Pharma and as of January 1, 2016 as Scientific Director at Lygature after the merger of CTMM and TI Pharma. In addition, from January 2013 onwards Ton is also Head of the European Screening Centre, part of the IMI European Lead Factory.

Sponsors & Partners
Main partner
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Award sponsor
AXON Lawyers
Award sponsor
Vereniging Innovatieve Geneesmiddelen
Global Investor Forum
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.